Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment

Authors: Mathewkutty, Shiny; McGuire, Darren K

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 5, May 2009 , pp. 541-549(9)

Publisher: Expert Reviews

Buy & download fulltext article:

OR

Price: $73.00 plus tax (Refund Policy)

Abstract:

The prevalence of Type 2 diabetes mellitus (DM) continues to increase globally and brings with it a parallel increase in the associated cardiovascular disease complications. Despite advances in evidence-based therapies for cardiovascular disease risk modification, many of which are especially effective among patients with DM, there remains a residual degree of cardiovascular disease risk associated with DM, yielding opportunity for continued clinical advances. Given the myriad perturbations of platelet function associated with DM, improvements in antiplatelet therapies hold particular promise for this high-risk population of patients, with emerging data from ex vivo assessments and clinical outcomes trials providing a basis of support for this concept.

Keywords: antiplatelet therapy; cardiovascular disease; diabetes mellitus

Document Type: Research article

DOI: http://dx.doi.org/10.1586/erc.09.30

Affiliations: 1: Resident, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Email: s8math@parknet.pmh.org

Publication date: 2009-05-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page